Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
becaplermin alpha-2-macroglobulin biotech NA drugbank Diabetes Mellitus[MeSHID:D003920]
Skin Ulcer[MeSHID:D012883]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 NA approved,investigational unknown
becaplermin platelet-derived growth factor receptor alpha biotech NA drugbank , DGIDB Diabetes Mellitus[MeSHID:D003920]
Skin Ulcer[MeSHID:D012883]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 3.86 approved,investigational agonist
becaplermin platelet-derived growth factor receptor alpha biotech NA drugbank , DGIDB Diabetes Mellitus[MeSHID:D003920]
Skin Ulcer[MeSHID:D012883]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 3.86 approved,investigational unknown
becaplermin platelet-derived growth factor receptor beta biotech Successful target TTD , drugbank , DGIDB Diabetes Mellitus[MeSHID:D003920]
Skin Ulcer[MeSHID:D012883]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 2.01 approved,investigational agonist
becaplermin platelet-derived growth factor receptor beta biotech Successful target TTD , drugbank , DGIDB Diabetes Mellitus[MeSHID:D003920]
Skin Ulcer[MeSHID:D012883]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 2.01 approved,investigational unknown
click here to return to the previous page